Key result
Preventive interventions for dyslipidemia and coronary risk factors reduce CHD events in postmenopausal women.
This review emphasizes the critical need to address the underrecognition and undertreatment of coronary risk factors, particularly dyslipidemia, in postmenopausal women to reduce CHD mortality.
May support targeted risk factor control in postmenopausal women; leaves open the need for prospective trials to guide implementation.
This review identifies coronary heart disease (CHD) as the leading cause of mortality among postmenopausal women and highlights the well-documented problem of underrecognition and undertreatment of women who are at risk for or who already have CHD. This undertreatment encompasses both preventive care (i.e., drug treatment for lipid management) and more invasive treatments (e.g., revascularization procedures). Preventive interventions to reduce dyslipidemia and control other coronary risk factors can lessen CHD mortality and morbidity in the postmenopausal woman.
No takes yet. Share an insight, caveat, or question.
Nanette K. Wenger (2000) conducted a review in Coronary heart disease. Preventive interventions (lipid management and risk factor control) was evaluated on CHD mortality and morbidity. Preventive interventions to reduce dyslipidemia and control other coronary risk factors can lessen CHD mortality and morbidity in postmenopausal women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: